Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis
Charles N. Zawatsky, Joshua K. Park, Jasmina Abdalla, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 16

Showing 16 citing articles:

Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Advances in targeted liquid chromatography‐tandem mass spectrometry methods for endocannabinoid and N‐acylethanolamine quantification in biological matrices: A systematic review
Khalisa Amir Hamzah, Natalie Turner, David S. Nichols, et al.
Mass Spectrometry Reviews (2024)
Open Access | Times Cited: 4
The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
Saoirse E. O’Sullivan, Andrew Yates, Richard K. Porter
Molecules (2021) Vol. 26, Iss. 20, pp. 6178-6178
Open Access | Times Cited: 29
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
Laetitia Jacquot, Océane Pointeau, Célia Roger-Villeboeuf, et al.
Frontiers in Nephrology (2023) Vol. 3
Open Access | Times Cited: 12
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
Muhammad Arif, Abhishek Basu, Kaelin M. Wolf, et al.
Advanced Science (2023) Vol. 10, Iss. 16
Open Access | Times Cited: 11
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB1R)
Leonard Mach, Anahid Omran, Jara Bouma, et al.
(2024)
Open Access | Times Cited: 3
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB1R)
Leonard Mach, Anahid Omran, Jara Bouma, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 3
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
Robert Ramer, Burkhard Hinz
Cells (2022) Vol. 11, Iss. 24, pp. 4102-4102
Open Access | Times Cited: 14
Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor
Samay Shivshankar, Josephine Nimely, Henry L. Puhl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5012-5012
Open Access | Times Cited: 2
Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB1R) Receptor with Reduced Lipophilicity
Malliga R. Iyer, Reşat Çınar, Casey M. Wood, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2374-2387
Closed Access | Times Cited: 11
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders
Szabolcs Dvorácskó, Alexa Herrerias, Anna Oliverio, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 11985-12004
Closed Access | Times Cited: 5
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Reşat Çınar, Abhishek Basu, Muhammad Arif, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis
Elias Carvalho Padilha, Mengbi Yang, Pranav Shah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115178-115178
Open Access | Times Cited: 2
Cannabinoids to Fight Chemotherapy-Induced Adverse Effects
Ana Bagüés, David Benítez, Raquel Abalo
Springer eBooks (2023), pp. 1-29
Closed Access
Cannabinoids to Fight Chemotherapy-Induced Adverse Effects
Ana Bagüés, David Benítez, Raquel Abalo
Springer eBooks (2023), pp. 1-28
Closed Access
4,5-Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1 (CB1R) receptor antagonists and their potential in medicinal applications
Malliga R. Iyer
Elsevier eBooks (2023), pp. 237-250
Closed Access
Page 1

Scroll to top